Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Anaptysbio (ANAB) Operating Expenses: 2015-2024

Historic Operating Expenses for Anaptysbio (ANAB) over the last 10 years, with Dec 2024 value amounting to $206.2 million.

  • Anaptysbio's Operating Expenses fell 21.14% to $41.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $198.1 million, marking a year-over-year decrease of 3.15%. This contributed to the annual value of $206.2 million for FY2024, which is 13.58% up from last year.
  • Anaptysbio's Operating Expenses amounted to $206.2 million in FY2024, which was up 13.58% from $181.6 million recorded in FY2023.
  • In the past 5 years, Anaptysbio's Operating Expenses registered a high of $206.2 million during FY2024, and its lowest value of $98.9 million during FY2020.
  • Its 3-year average for Operating Expenses is $171.1 million, with a median of $181.6 million in 2023.
  • In the last 5 years, Anaptysbio's Operating Expenses decreased by 14.34% in 2020 and then surged by 44.74% in 2023.
  • Over the past 5 years, Anaptysbio's Operating Expenses (Yearly) stood at $98.9 million in 2020, then rose by 21.35% to $120.0 million in 2021, then grew by 4.54% to $125.4 million in 2022, then soared by 44.74% to $181.6 million in 2023, then increased by 13.58% to $206.2 million in 2024.